Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Wicks

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Annals of the Rheumatic Diseases|June 18, 2014
Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritisD E A Greven, E S Cohen, D M Gerlag, et al.
Clinical & Translational Immunology|April 24, 2023
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritisDragana Dragoljevic, Man Kit Sam Lee, Gerard Pernes, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2018
Autoinflammatory mutation in NLRC4 reveals a leucine-rich repeat (LRR)-LRR oligomerization interfaceFiona Moghaddas, Ping Zeng, Yuxia Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory ArthritisIan K Campbell, David Leong, Kirsten M Edwards, et al.
Cell Death and Differentiation|February 9, 2023
MLKL deficiency protects against low-grade, sterile inflammation in aged miceEmma C Tovey Crutchfield, Sarah E Garnish, Jessica Day, et al.
Nature Communications|February 19, 2015
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLKate E Lawlor, Nufail Khan, Alison Mildenhall, et al.
Immunity|September 17, 2017
SIDT2 Transports Extracellular dsRNA into the Cytoplasm for Innate Immune RecognitionTan A Nguyen, Blake R C Smith, Michelle D Tate, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2018
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case seriesEmma L Mitchell, Peter Kar Han Lau, Chloe Khoo, et al.
Blood Advances|June 8, 2021
BCL-XL antagonism selectively reduces neutrophil life span within inflamed tissues without causing neutropeniaEmma M Carrington, Cynthia Louis, Tobias Kratina, et al.
Cell Reports|October 9, 2024
Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activityEthan P Oxley, Nadia J Kershaw, Cynthia Louis, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Annals of the Rheumatic Diseases|June 18, 2014
Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritisD E A Greven, E S Cohen, D M Gerlag, et al.
Clinical & Translational Immunology|April 24, 2023
Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritisDragana Dragoljevic, Man Kit Sam Lee, Gerard Pernes, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2018
Autoinflammatory mutation in NLRC4 reveals a leucine-rich repeat (LRR)-LRR oligomerization interfaceFiona Moghaddas, Ping Zeng, Yuxia Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 4, 2016
Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory ArthritisIan K Campbell, David Leong, Kirsten M Edwards, et al.
Cell Death and Differentiation|February 9, 2023
MLKL deficiency protects against low-grade, sterile inflammation in aged miceEmma C Tovey Crutchfield, Sarah E Garnish, Jessica Day, et al.
Nature Communications|February 19, 2015
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLKate E Lawlor, Nufail Khan, Alison Mildenhall, et al.
Immunity|September 17, 2017
SIDT2 Transports Extracellular dsRNA into the Cytoplasm for Innate Immune RecognitionTan A Nguyen, Blake R C Smith, Michelle D Tate, et al.
European Journal of Cancer (Oxford, England : 1990)|November 16, 2018
Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case seriesEmma L Mitchell, Peter Kar Han Lau, Chloe Khoo, et al.
Blood Advances|June 8, 2021
BCL-XL antagonism selectively reduces neutrophil life span within inflamed tissues without causing neutropeniaEmma M Carrington, Cynthia Louis, Tobias Kratina, et al.
Cell Reports|October 9, 2024
Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activityEthan P Oxley, Nadia J Kershaw, Cynthia Louis, et al.
Pageof 18